DESIGNED FOR IMPACT
CLINICAL TRIAL INFORMATION AND RECRUITMENT
TG Therapeutics is committed to the development of innovative medicines that deliver novel treatments for patients suffering from B-cell diseases. An integral part of achieving this goal is the conduct of robust and efficient clinical trials at the highest standards of quality attainable.
Information on all of TG Therapeutics’ ongoing clinical trials, including information for healthcare providers and patients interested in participating in any ongoing clinical trials, can be found at www.ClinicalTrials.gov.
OUR PHASE 3 AND POST MARKETING PROGRAMS IN MULTIPLE SCLEROSIS
OUR CURRENT TRIALS IN MYASTHENIA GRAVIS
